SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-18-007680
Filing Date
2018-12-13
Accepted
2018-12-13 18:55:41
Documents
2
Period of Report
2018-12-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-43509.html 3  
1 PRIMARY DOCUMENT marketforms-43509.xml 3 1705
2 POA DOCUMENT poa.htm EX-24 3018
  Complete submission text file 0001214659-18-007680.txt   6121
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9393 TOWNE CENTRE DRIVE STE 200 SAN DIEGO CA 92121
Business Address
Martinez Maria E (Reporting) CIK: 0001761768 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 181234276